Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma.
about
Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular CarcinomaEnvironmental immune disruptors, inflammation and cancer riskIn vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analogTRAIL-mediated apoptosis in breast cancer cells cultured as 3D spheroidsProstanoid EP1 receptor as the target of (-)-epigallocatechin-3-gallate in suppressing hepatocellular carcinoma cells in vitro.Hepatopoietin Cn suppresses apoptosis of human hepatocellular carcinoma cells by up-regulating myeloid cell leukemia-1.Acquired activation of the Akt/cyclooxygenase-2/Mcl-1 pathway renders lung cancer cells resistant to apoptosisAnti-apoptotic effects of osteopontin through the up-regulation of Mcl-1 in gastrointestinal stromal tumors.Celecoxib-induced apoptosis is enhanced by ABT-737 and by inhibition of autophagy in human colorectal cancer cellsCyclooxygenase-2 is a target of microRNA-16 in human hepatoma cellsTransgenic mice expressing cyclooxygenase-2 in hepatocytes reveal a minor contribution of this enzyme to chemical hepatocarcinogenesisThe effect of β-adrenergic blockade and COX-2 inhibition on healing of colon, muscle, and skin in rats undergoing colonic anastomosis.Cardiovascular effects of Phaleria macrocarpa extracts combined with mainstay FAC regimen for breast cancer.PDE5 inhibitors enhance celecoxib killing in multiple tumor types.Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells.Evaluation of epigenetic modulation of cyclooxygenase-2 as a prognostic marker for hepatocellular carcinomaCyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E2 receptors, EP2 and EP4.Genetic ablation of cyclooxygenase-2 in keratinocytes produces a cell-autonomous defect in tumor formation.Tumor necrosis factor-alpha potentiates the cytotoxicity of amiodarone in Hepa1c1c7 cells: roles of caspase activation and oxidative stressThe role of apoptosis in therapy and prophylaxis of epithelial tumours by nonsteroidal anti-inflammatory drugs (NSAIDs).Effects of celecoxib on ionic currents and spontaneous firing in rat retinal neurons.E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer.Macrophage EP4 deficiency increases apoptosis and suppresses early atherosclerosis.Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis.Neoplasms of the hepatobiliary system: clinical presentation, molecular pathways and diagnostics.Regulation of MicroRNA 183 by Cyclooxygenase 2 in Liver Is DEAD-Box Helicase p68 (DDX5) Dependent: Role in Insulin Signaling.Celecoxib-induced increase in cytosolic Ca(2+) levels and apoptosis in HA59T human hepatoma cells.Enhanced 5-fluorouracil cytotoxicity in high COX-2 expressing hepatocellular carcinoma cells by wogonin via the PI3K/Akt pathway.The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth and induces apoptosis of human glioblastoma cells via the NF-κB pathway.p-HPEA-EDA, a phenolic compound of virgin olive oil, activates AMP-activated protein kinase to inhibit carcinogenesis.Combined inhibitory effects of celecoxib and fluvastatin on the growth of human hepatocellular carcinoma xenografts in nude mice.Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.Dysregulation of apoptosis in hepatocellular carcinoma cells.Black currant phytoconstituents exert chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis by suppression of the inflammatory response.Action of celecoxib on hepatic metabolic changes induced by the Walker-256 tumour in rats.Blocking COX-2 induces apoptosis and inhibits cell proliferation via the Akt/survivin- and Akt/ID3 pathway in low-grade-glioma.Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults.
P2860
Q26767372-ED940E8F-5747-4BA8-BA9F-AAB214101318Q28080870-88F36E4B-70B5-49D6-9CE9-E4977B271FDCQ28484672-BBC32876-BD1A-4A17-8F4A-226C341EB031Q28544399-A5FC1C9C-0FDF-4672-A75B-C3EAEA28484BQ33567396-502032C7-DBA6-4D08-88FD-9D3D52C30AFBQ33590801-7601280F-D26C-427E-A1E5-04C72237FD8EQ33714703-C291D048-43E9-43A5-8A4D-169FA24F7477Q33841673-FF6D8C71-56AA-43A0-B099-34DD8642217AQ34168046-DF00308E-8350-40F2-BAF9-28831F9E9BB6Q34506147-F19B1D01-93D0-4ABC-A854-FD73E81D084BQ34756135-09087DCA-8B71-4DED-B94A-CDB854066CFFQ35148963-574605C7-5A14-4F09-9379-E0511CAA4FB7Q35232251-AB6C25AD-05CF-46A9-8B8F-17B27DC66940Q35430943-D42767CA-D0FF-43E1-BC8C-4C8991D9C31FQ35820816-4F93A1F7-78BD-4CBE-A282-ECE1704914A8Q36143166-4DA1C48C-0344-4F7A-B422-18A61CF6E6F0Q36153789-9CB2BDAB-04F3-4C95-9D78-3942C71CF517Q36401953-A461DBB3-3302-450C-9C15-6F7B14A74337Q36509054-7D3B2BE2-15E1-42EA-8E03-4913B8B62BBEQ36815314-2483F2DB-D31E-47E1-8D95-6790A4567366Q36965364-9361E2D0-244B-4DDA-95AA-BC8E5F0E1C7BQ37037477-B3EE8E81-9EB9-4A4A-9502-91722B284ABFQ37039326-7C579DC0-F25A-4119-8E4A-92DA4DB682BFQ37412219-3677CA39-C38B-4183-BF15-0D68774B6391Q37801938-073D9DD4-327E-44D8-8A80-1FC423B17BE9Q38876354-03FB6759-3AF5-4106-B6D6-C5BF57FBD098Q38980297-FCF1C647-CA03-4803-8627-9BA7DAE1D9B5Q39125279-8F497324-3A8B-492A-B738-2CB641548E51Q39489252-CF0002F1-EE7C-4D3F-A2FF-53FB3D4AF5EFQ39610419-685E72C3-16DF-4E7C-8765-8C8CA70F4B1EQ39647685-129230BA-6F2D-4ED4-AEA8-6F18A2B2D2FCQ42376638-A868C07B-DB26-4277-B492-6ECE4E269D20Q43166036-02EDE80F-FD07-442D-A0E0-C4F0AD6143DFQ45227714-966092F6-CEDB-4D5C-97DD-0AA36FAE858FQ46970976-76A4491C-4C99-4555-AB1F-E41A2503CE3AQ48268726-85A0A835-F6D3-474B-AC30-852FC2713315Q53176915-619AF550-57DE-4BD4-A0DB-9CEF6CB6DACA
P2860
Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Cyclooxygenase-2 inhibition in ...... a in hepatocellular carcinoma.
@en
type
label
Cyclooxygenase-2 inhibition in ...... a in hepatocellular carcinoma.
@en
prefLabel
Cyclooxygenase-2 inhibition in ...... a in hepatocellular carcinoma.
@en
P2093
P1433
P1476
Cyclooxygenase-2 inhibition in ...... a in hepatocellular carcinoma.
@en
P2093
Andreas F Koch
Anke M Haugg
Binje Fleischer
Christian Trautwein
Christoph Michalski
Henning Schulze-Bergkamen
Henning Walczak
Martina Müller
Michael A Kern
Peter H Krammer
P304
P356
10.1158/0008-5472.CAN-06-0325
P407
P577
2006-07-01T00:00:00Z